Discover
The Peptide Effect
The Peptide Effect
Author: Peptides Made Simple
Subscribed: 65Played: 1,717Subscribe
Share
Description
The Peptide Effect is your go-to podcast for breaking down peptides, performance compounds, and cutting-edge wellness science in a way that actually makes sense.
From fat loss and muscle growth to anti-aging, recovery, hormones, brain health, and biohacking, we cover the most talked-about peptides and protocols—what they do, how they work, and what people are really using them for.
Whether you’re brand new to peptides or already deep in the game, this show delivers simple explanations, real-world insight, and practical conversations to help you learn smarter, optimize better, and stay ahead of the curve.
Educational, engaging, and always curious—welcome to The Peptide Effect.
178 Episodes
Reverse
🧬💊 ICOTYDE: THE BREAKTHROUGH ORAL PEPTIDE TAKING ON ARTHRITIS — NO INJECTIONS REQUIRED!Could a simple daily pill change the future of peptide medicine and inflammatory arthritis treatment?A groundbreaking oral peptide called ICOTYDE (icotrokinra) is making headlines! Already FDA-approved for certain patients with plaque psoriasis, this innovative medication is now showing promising Phase 3 clinical trial results for psoriatic arthritis.And here’s what makes it so exciting… It’s a peptide you SWALLOW instead of inject!In this episode of The Peptide Effect, we’re diving into the science behind ICOTYDE, how it targets inflammation, and why this development could open the door to an entirely new generation of oral peptide medications.🔬 What we’re covering:💊 No injections required! How scientists engineered a peptide that can be taken orally.🧬 The science of ICOTYDE: How blocking the IL-23 receptor helps regulate inflammatory signaling.🔥 Arthritis and inflammation: Understanding psoriasis, psoriatic arthritis, and the immune system.📊 The latest clinical trial results: Why 58% of ICOTYDE patients achieved an ACR20 response compared with 41% receiving placebo.💪 Joint pain and mobility: What the research reveals about improving symptoms and physical function.✨ Skin improvements: How ICOTYDE is helping patients with moderate to severe plaque psoriasis.⚠️ Side effects and safety: What researchers know and what questions remain.🔮 The future of oral peptides: Could this technology transform how other peptide medications are developed?Is ICOTYDE the beginning of a new era in peptide medicine?We’re breaking down the clinical evidence, separating scientific breakthroughs from marketing hype, and exploring why this medication is generating excitement in both dermatology and rheumatology.🎙️ Whether you’re interested in peptide science, autoimmune diseases, inflammation, arthritis research, or the future of medicine, this is an episode you won’t want to miss!⚠️ Medical Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. ICOTYDE is FDA-approved for certain patients with plaque psoriasis, but its use for psoriatic arthritis remains investigational. Always consult a qualified healthcare professional before making treatment decisions.🎧 The Peptide EffectThanks for listening, keep learning and stay curious!#ThePeptideEffect #ICOTYDE #Icotrokinra #PeptideScience #OralPeptides #PsoriaticArthritis #Psoriasis #ArthritisResearch #Inflammation #IL23 #AutoimmuneDisease #PeptideNews #MedicalBreakthroughs #JohnsonAndJohnson #FutureOfMedicine
🧬🔥 RETATRUTIDE VS. OZEMPIC: THE RESULTS ARE IN!Could the next generation of weight-loss peptides leave Ozempic behind?In a groundbreaking Phase 3 clinical trial, Eli Lilly’s investigational triple agonist, retatrutide, delivered more than DOUBLE the average weight loss of Ozempic at its highest approved diabetes dose!In this episode of The Peptide Effect, we’re breaking down the latest head-to-head clinical trial results and exploring what they could mean for the future of weight loss, diabetes treatment, and metabolic health.💉 Here’s what we’re covering:🔬 Retatrutide vs. Ozempic: The actual clinical trial results.⚖️ Average weight loss of 19.5%–20.9% with retatrutide compared to 9.4% with Ozempic.🧬 Triple agonists explained: How GLP-1, GIP, and glucagon work together.🩸 Blood sugar control: Why retatrutide produced greater A1C reductions.🔥 The science behind metabolism, appetite suppression, and energy expenditure.⚠️ Side effects, safety concerns, and why more weight loss doesn’t always mean a better medication.💪 Muscle preservation, body composition, and the challenges of maintaining weight loss.🔮 What’s next? Retatrutide vs. tirzepatide and the future of metabolic medicine.Is retatrutide the future of weight-loss treatment, or are we getting ahead of the science?We’re separating the research from the hype and giving you the facts behind one of the most talked-about peptides in development.🎙️ Whether you’re interested in GLP-1 medications, peptide science, diabetes research, or the future of obesity treatment, you won’t want to miss this episode!⚠️ Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Retatrutide remains investigational and is not FDA-approved. Clinical trial results do not guarantee individual outcomes.🎧 The Peptide EffectThanks for listening, keep learning and stay curious!#ThePeptideEffect #Retatrutide #Ozempic #GLP1 #GLP3 #TripleAgonist #Tirzepatide #Semaglutide #WeightLossResearch #PeptideScience #PeptideNews #MetabolicHealth #DiabetesResearch #EliLilly
🧬 The Peptide Comeback: 6 Research Peptides Get a Regulatory Break — What You Need to KnowBig news in the peptide world! The U.S. Department of Health and Human Services has announced a major regulatory shift involving six popular research peptides: BPC-157, TB-500, KPV, MOTS-c, Epitalon, and Semax.But does this mean they’re finally legal? Can compounding pharmacies start offering them? And does this mean the FDA considers them safe?In this episode of The Peptide Effect, we’re breaking down what this announcement actually means, why these peptides were previously restricted, and what could happen next.🔬 We’ll explore the science behind all six peptides, including their potential roles in tissue repair, inflammation, metabolism, longevity, and neurological health.💉 We’ll also discuss the new compounding requirements, manufacturing standards, patient safety concerns, and why regulatory access does NOT mean FDA approval.Whether you’re a longtime peptide enthusiast or just beginning to explore peptide science, this is an episode you don’t want to miss!⚠️ Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Many research peptides are not FDA-approved, and their safety and effectiveness in humans remain uncertain.🎙️ The Peptide Effect — Thanks for listening, keep learning and stay curious!#ThePeptideEffect #PeptideNews #BPC157 #TB500 #KPV #MOTSc #Epitalon #Semax #PeptideResearch #PeptideScience #FDA #Longevity #Biohacking #CompoundingPharmacy
A Hollywood legend, two experimental peptides, and a fatal allergic reaction.In this episode of The Peptide Effect, we examine the tragic death of Australian actor, martial artist, and stunt coordinator Richard Norton, whose death was linked to injections of CJC-1295 and Ipamorelin.We break down what happened, why he was using these peptides, the warning signs he experienced, his reported dosing mistakes, and the coroner’s findings.We also explore the growing number of severe allergic reactions associated with experimental peptides, the potential risks of anaphylaxis, and why Australian authorities are considering stricter regulations.Does this tragedy mean peptides are dangerous, or is there more to the story?Join us as we separate facts from fear, examine the science, and discuss what this case means for the peptide community.Disclaimer: This episode is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before considering experimental treatments.#ThePeptideEffect #RichardNorton #Peptides #CJC1295 #Ipamorelin #PeptideSafety #Anaphylaxis #PeptideResearch
Are weight-loss peptides a treat, or is the marketing playing tricks? 🎃 In this Halloween episode of The Peptide Effect, we explore AOD-9604, cagrilintide, semaglutide, tirzepatide, and retatrutide—unmasking their differences and separating promising research from spooky sales pitches.From food noise and fullness to fat-loss claims and peptide stacks, we shine a flashlight on what the evidence shows, what remains uncertain, and why stronger appetite suppression is not always better. Expect science, Halloween humor, and a reminder that enjoying a little candy does not require a metabolic exorcism.For education and entertainment only. This episode is not medical advice; some compounds discussed are investigational or not approved for weight management.








